Abiopharma

Regal Rexnord Names Mark Klossner EVP & President, Industrial Powertrain Solutions (IPS), Jerry Morton to Retire as EVP & President, IPS

TIC Solutions Announces Debt Repricing

Seaport Therapeutics to Participate in Two Upcoming Investor Conferences

Summit Midstream Corporation Announces Inaugural $35 Million Stock Repurchase Program

Actinium Pharmaceuticals Presents New Radiochemistry Data at SNMMI 2026 Demonstrating That CAR Optimization Improves Tumor Targeting and Pharmacokinetics of Actinium-225 Radioconjugates

Actinium Pharmaceuticals Presents New Radiochemistry Data at SNMMI 2026 Demonstrating That CAR Optimization Improves Tumor Targeting and Pharmacokinetics of Actinium-225 Radioconjugates

Canadian Solar Releases 2025 Corporate Sustainability Report

Actuate Therapeutics Announces ASCO Poster Presentations Demonstrating Compelling Clinical and Biomarker Data for Elraglusib in First-Line Metastatic Pancreatic Cancer

Bristol Myers Squibb - U.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Supplemental New Drug Application for Camzyos (mavacamten) to Treat Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)

Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States